drugset / Trial / NCT00005096
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
Phase 2
Completed
19 enrolled
Dana-Farber Cancer Institute
National Cancer Institute (NCI) · collabRhone-Poulenc Rorer · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients who have stage II or stage III prostate cancer.
Timeline
- Start
- 1999-12
- Primary completion
- 2002-06
- Completion
- 2002-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |